{"id":"W2596564154","doi":"10.1200/jco.2006.24.18_suppl.7608","title":"Update of melphalan 280 mg/m<sup>2 </sup>plus amifostine cytoprotection before autologous stem cell transplantation as part of initial therapy in multiple myeloma patients","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melphalan; Multiple myeloma; Regimen; Internal medicine; Transplantation; Autologous stem-cell transplantation; Amifostine; Urology; Surgery; Clinical endpoint; AL amyloidosis; Gastroenterology; Toxicity; Clinical trial; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001410811,0.0002595259,0.000720702,0.0003742101,0.000194203,0.00074193,0.0005511388,0.0008238931,0.0009575671],"category_scores_gemma":[0.001525966,0.0001637674,0.0004395032,0.0004497461,0.00013225,0.0003777281,0.0001529068,0.001000318,0.000354677],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006541706,"about_ca_system_score_gemma":0.0006303104,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001116005,"about_ca_topic_score_gemma":0.003566941,"domain_scores_codex":[0.9996338,0.0001021251,0.0001035319,0.0000281902,0.00009990379,0.00003251915],"domain_scores_gemma":[0.9989485,0.0003557852,0.000172931,0.00002702628,0.0003158392,0.0001800073],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.007921504,0.000894437,0.0267897,0.002333026,0.0003967678,0.002389404,0.0002631476,0.0008292252,0.01421465,0.0005031463,0.04544369,0.8980214],"study_design_scores_gemma":[0.003309956,0.01764615,0.2284331,0.001394735,0.002062285,0.01298267,0.0002823094,0.001935464,0.01155091,0.000330361,0.7200096,0.00006253953],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6455144,0.2775145,0.003549603,0.03240645,0.004363018,0.00051763,0.001378034,0.0005297597,0.0342266],"genre_scores_gemma":[0.7980664,0.1479288,0.009590263,0.02527011,0.008483656,0.000456977,0.002949876,0.00008660077,0.00716743],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001410811,"threshold_uncertainty_score":0.00746119,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07193456100702537,"score_gpt":0.4108481933375746,"score_spread":0.3389136323305492,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}